Valeant Pharmaceuticals North America has donated $250,000 to the National Coalition Against Domestic Violence (NCADV). The donation is a reflection of Valeant's ongoing support and commitment to the well-being of women, and is the first of four checks the company will present to NCADV in a one year period for a combined donation goal of $1 million.
"NCADV is thrilled to be working with Valeant as a partner in our efforts to end violence in the home," said Rita Smith, executive director of NCADV. "Corporations have the ability to increase the awareness of resources and information about domestic violence to a much larger audience than we can alone, and as a result, together we can make a difference in so many more lives of people who are struggling to get free from the violence."
"Valeant's partnership with the NCADV provides us a tremendous opportunity to make a difference in the lives of those impacted by domestic violence," said Ryan Weldon, executive vice president, Valeant Pharmaceuticals. "We make these efforts on behalf of our employees and the consumers and healthcare professionals that support this cause by using our products. We hope this collaboration will continue to grow and enable the NCADV in its mission to end domestic violence."
Valeant partnered with NCADV in October 2013. To date, the partnership has helped 19,000 women by supporting NCADV in:
• Expanding relationships with associations that provide services to victims of violence
• Developing partnerships in the creation of information and materials addressing specific health issues and intimate partner violence
• Expanding topics of health and wellness materials for victims and survivors of domestic violence
• Creating training materials for service providers on how to best serve survivors struggling with health and wellness issues
To learn more, visit www.enddomesticviolence.valeant.com
